JohnW.WinkelmanMD

Sleep Medicine

Associate Professor in Psychiatry at Harvard Medical School and chief of the Sleep Disorders Clinical Research Program in the Department of Psychiatry at Massachusetts General Hospital

Join to view full profile

Dr. Winkelman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Winkelman's full profile

Already have an account?

Office
55 Fruit St
Boston, MA 02114
Phone+1 617-724-7426

Education & Training

Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1988 - 1991
University of California (San Francisco)/Mount ZionInternship, Internal Medicine, 1987 - 1988
Harvard Medical SchoolClass of 1987

Certifications & Licensure

MA State Medical License 1991 - 2026
ME State Medical License 2021 - 2026
CA State Medical License 1993 - 2025
American Board of Psychiatry and Neurology Psychiatry
American Board of Psychiatry and Neurology Sleep Medicine

Clinical Trials

A Double Blind Crossover Trial of Levetiracetam (Keppra®) and Placebo in the Treatment of Restless Legs Syndrome (RLS) Start of enrollment: 2003 Nov 01
Completed
Phase 2
Sleep Loss and Mechanisms of Impaired Glucose Metabolism Start of enrollment: 2006 Mar 01
Completed
Not Applicable
Efficacy and Safety of Topiramate in the Treatment of Sleep-Related Eating Disorder Start of enrollment: 2008 Jan 01
Completed
Early Phase 1
Altered Brain GABA and Glutamate in Restless Legs Syndrome Start of enrollment: 2010 Apr 01
Completed
Switching From Oral Dopamine Agonists to Rotigotine Start of enrollment: 2014 Aug 01
Completed
Phase 4
Butrans for Treatment of Restless Legs Syndrome Start of enrollment: 2014 Apr 01
Withdrawn
Phase 4
Suvorexant on Sleep Disturbance in Patients With Chronic Insomnia and Suboptimally Controlled Type 2 Diabetes Start of enrollment: 2019 Mar 15
Completed
Phase 4
Efficacy of Suvorexant in Patients With Effectively Treated Restless Legs Syndrome and Persistent Chronic Insomnia Start of enrollment: 2021 Aug 12
Completed
Phase 4
Join now to see all

Publications & Presentations

PubMed

908 citations
Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationa...
Richard P. Allen, Daniel L. Picchietti, Diego Garcia-Borreguero, William G. Ondo, Arthur S. Walters
Sleep Medicine. 2014-08-01
123 citations
World Association of Sleep Medicine (WASM) 2016 standards for recording and scoring leg movements in polysomnograms developed by a joint task force from the Internatio...
Raffaele Ferri, Stephany Fulda, Richard P. Allen, Marco Zucconi, Oliviero Bruni
Sleep Medicine. 2016-10-01
9 citations
Drug Treatment of Restless Legs Syndrome in Older Adults
Emmanuel H. During, John W. Winkelman
Drugs & Aging. 2019-10-01

Other

Nocturnal leg cramps
Winkelman JW
http://www.uptodate.com/contents/nocturnal-leg-cramps
UpToDate, Wolters Kluwer Health - 2013-01-22

Press Mentions

Study Revolutionize Restless Legs Syndrome TreatmentNovember 13th, 2024
Summary of New Clinical Practice Guideline for RLS and PLMDNovember 13th, 2024
Updated Treatment Recommendations for Restless Legs Syndrome (RLS)November 6th, 2024
Join now to see all

Grant Support

Eszopiclone To Counteract Adverse Metabolic Consequences Of Primary InsomniaNational Center For Research Resources2007–2008